
Rosa Bacchetta
Project Leader · Stanford Health Care
Credentials: · ·
History
- Present
- Present
- Present
- 1991–1992
- 1988–1991
- 1983–1987

Research
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans
Review · Immunological Reviews · 2006 · 919 citations
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Nature Biotechnology · 2015 · 885 citations
International Immunology · 2007 · 720 citations

88 papers

Luigi Notarangelo
7 papers

7 papers · 4 as a resident
- SM
6 papers

5 papers

5 papers

5 papers
- TT
5 papers
Grants
- 2026–2028
Engineered Treg Therapy for Pediatric Crohn's Disease.
National Center for Advancing Translational Sciences · R21
Contact PI · $427.1K · Stanford University
- 2022–2027
Food and Drug Administration · R01
Contact PI · $2.7M · Stanford University
- 2016–2018
Genome Editing to Rescue FOXP3 Deficiency in IPEX Syndrome
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $438.7K · Stanford University
Clinical trials
- 2021–2029
Sub-investigator · Recruiting · Phase 1
Porteus, Matthew, MD


